Newest medicines work just as well at half dosage for stable psoriasis, new study finds

Three-quarters of people who respond well to the newest types of biologics for psoriasis can safely reduce their dosage, often even by half.

These medications then work just as effectively, according to a study led by Radboud University Medical Center and Ghent University Hospital.

The finding results in fewer injections and saves up to €8,500 (~$9,900) per patient per year.

The study is published in The Lancet Regional Health—Europe. ...